Gupta Suneel
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Gupta Suneel. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| PTGX | Chief Development Officer | Option Exercise | 450 | $12.17 | $5,477 | Nov 26, 2024 |
| PTGX | Chief Development Officer | Tax Withholding | 4,282 | $29.53 | $126,447 | Feb 26, 2024 |
| PTGX | Chief Development Officer | Sale | 5,000 | $25.00 | $125,000 | Jan 9, 2024 |
| PTGX | Chief Development Officer | Award / Grant | 19,250 | — | — | Jan 2, 2024 |
| PTGX | Chief Development Officer | Option Exercise | 20,000 | $7.38 | $147,600 | Oct 19, 2023 |
| PTGX | Chief Development Officer | Award / Grant | 12,000 | — | — | May 31, 2023 |
| PTGX | Chief Development Officer | Award / Grant | 20,625 | — | — | Jan 16, 2023 |
| PTGX | Chief Development Officer | Option Exercise | 40,000 | $7.38 | $295,200 | Apr 26, 2022 |
| PTGX | Chief Development Officer | Tax Withholding | 649 | $24.28 | $15,758 | Feb 28, 2022 |
| PTGX | Chief Development Officer | Award / Grant | 12,500 | — | — | Feb 15, 2022 |
| PTGX | Chief Development Officer | Award / Grant | 12,000 | — | — | Feb 26, 2021 |
| PTGX | EVP Clinical Operations | Purchase | 30,000 | $5.13 | $153,900 | Dec 3, 2019 |
| PTGX | EVP Clinical Operations | Award / Grant | 7,500 | — | — | Feb 28, 2019 |